Truist Securities Maintains Hold on Amrize, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 70.3%

Neg 70.3% Neu 0% Pos 0%

Truist Securities analyst Keith Hughes maintains Amrize (NYSE:AMRZ) with a Hold and lowers the price target from $48 to $35.